Related Experiment Video

Updated: Jun 1, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Anticancer gold(I)-phosphine complexes as potent autophagy-inducing agents

Songhai Tian1, Fung-Ming Siu, Steven C F Kui

  • 1Department of Chemistry, State Key Laboratory on Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong SAR, China.

Chemical Communications (Cambridge, England)
|May 18, 2011
PubMed

Insights

Certain gold(I)-phosphine complexes show strong potential as anticancer agents by effectively inducing autophagy, a cellular process, in cancer cells.

Area of Science:

  • Medicinal Chemistry
  • Cell Biology
  • Cancer Research

Background:

  • Autophagy plays a complex role in cancer, acting as both a tumor suppressor and a survival mechanism.
  • Gold complexes are explored for their therapeutic potential, but their mechanisms in cancer remain under investigation.
  • Targeting cellular processes like autophagy offers novel strategies for cancer treatment.

Purpose of the Study:

  • To investigate the autophagy-modulating effects of novel gold(I)-phosphine complexes.
  • To evaluate the potential of these complexes as anticancer agents through autophagy induction.
  • To establish a link between chemical structure and biological activity in gold-based anticancer drugs.

Main Methods:

  • Synthesis and characterization of a panel of gold(I)-phosphine complexes.
  • In vitro evaluation of cytotoxicity against various human cancer cell lines.
  • Assessment of autophagy induction using specific biomarkers (e.g., LC3, p62) and microscopy.
  • Analysis of the impact of autophagy modulation on cancer cell viability.

Main Results:

  • A series of gold(I)-phosphine complexes demonstrated significant anticancer activity.
  • These complexes were found to potently induce autophagy in treated cancer cells.
  • The observed autophagy induction correlated with increased cancer cell death.
  • Specific structural features of the phosphine ligands influenced the efficacy of autophagy induction.

Conclusions:

  • Gold(I)-phosphine complexes represent a promising class of compounds for cancer therapy.
  • Induction of autophagy is a key mechanism by which these complexes exert their anticancer effects.
  • Further development of these complexes could lead to new therapeutic strategies targeting cancer cell survival pathways.

More Related Videos

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...